Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Invitae Corp (NVTA)

Invitae Corp (NVTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,785,657
  • Shares Outstanding, K 96,522
  • Annual Sales, $ 147,700 K
  • Annual Income, $ -129,360 K
  • 60-Month Beta 2.45
  • Price/Sales 8.05
  • Price/Cash Flow N/A
  • Price/Book 4.42

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.68
  • Number of Estimates 5
  • High Estimate -0.47
  • Low Estimate -1.11
  • Prior Year -0.40
  • Growth Rate Est. (year over year) -70.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.11 +20.55%
on 12/31/19
20.40 -10.71%
on 01/17/20
+1.26 (+7.40%)
since 12/24/19
3-Month
14.35 +26.95%
on 11/07/19
20.79 -12.39%
on 11/26/19
+1.52 (+9.14%)
since 10/24/19
52-Week
13.00 +40.12%
on 02/05/19
28.75 -36.64%
on 08/07/19
+3.78 (+26.23%)
since 01/24/19

Most Recent Stories

More News
Relatively Good Performance Detected in Shares of Akebia Therapeut in the Biotechnology Industry (AKBA , FOLD , NVTA , BPMC , CTMX )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

AKBA : 7.93 (-7.47%)
FOLD : 8.94 (-3.56%)
NVTA : 18.35 (-0.81%)
Watch for Invitae Corp to Potentially Pullback After Gaining 7.72% Yesterday

Invitae Corp (NYSE:NVTA) traded in a range yesterday that spanned from a low of $17.51 to a high of $18.53. Yesterday, the shares gained 7.7%, which took the trading range above the 3-day high of $17.12...

NVTA : 18.35 (-0.81%)
Invitae preliminary 2019 financial results demonstrate strong momentum with nearly 60% growth in test volume and more than 45% growth in revenue year-over-year

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, announced preliminary unaudited full-year 2019 results, driving strong growth in volume and revenues, signaling continued momentum...

NVTA : 18.35 (-0.81%)
Behind the Seizure® Program Further Expands Access to Genetic Testing for Children to Speed the Diagnosis of Genetic Epilepsy

Today BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Invitae Corporation (NYSE: NVTA) announced that Biogen (NASDAQ: BIIB), Encoded Therapeutics, Neurogene, Praxis Precision Medicines and PTC Therapeutics...

PTCT : 51.92 (-2.64%)
BMRN : 86.15 (+0.61%)
BIIB : 278.14 (-2.14%)
NVTA : 18.35 (-0.81%)
STOK : 23.66 (-6.33%)
Invitae to Present at the 38th Annual J.P. Morgan Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the 38th Annual J.P. Morgan Healthcare...

JPM : 133.15 (-2.48%)
NVTA : 18.35 (-0.81%)
Small Gains Still Bring New Records

Small Gains Still Bring New Records

CDAY : 71.58 (-1.38%)
WWE : 59.66 (-4.48%)
ERI : 59.20 (-2.37%)
WYNN : 134.75 (-3.13%)
GH : 80.04 (-1.82%)
NVTA : 18.35 (-0.81%)
KERN : 8.78 (-6.10%)
RCEL : 9.39 (-1.88%)
Invitae Announces Program with BioMarin to Expand Access to Genetic Testing for Skeletal Dysplasias

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of Discover Dysplasias(TM), an initiative with BioMarin Pharmaceutical to offer genetic testing at no charge to patients...

NVTA : 18.35 (-0.81%)
Bull of the Day: Guardant Health (GH)

Bull of the Day: Guardant Health (GH)

NVTA : 18.35 (-0.81%)
GH : 80.04 (-1.82%)
Stocks Rebound and Hang Onto Recent Gains

Stocks Rebound and Hang Onto Recent Gains

ORI : 23.38 (+3.09%)
AOBC : 9.18 (-0.33%)
RLGY : 10.28 (-0.68%)
BLUE : 87.26 (-2.74%)
TRHC : 53.01 (-7.28%)
NVTA : 18.35 (-0.81%)
NGM Bio Announces Appointment of Shelly Guyer to Board of Directors

NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a clinical stage biotechnology company focused on developing transformative therapeutics for patients, today announced the expansion of its Board of Directors...

NGM : 17.45 (-5.16%)
NVTA : 18.35 (-0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade NVTA with:

Business Summary

Invitae Corporation is engaged in genetic diagnostics for hereditary disorders which include breast, colon and pancreatic cancer. It operates primarily in the United States, Israel and internationally. Invitae Corporation is headquartered in San Francisco, California.

See More

Key Turning Points

2nd Resistance Point 19.03
1st Resistance Point 18.76
Last Price 18.35
1st Support Level 18.19
2nd Support Level 17.89

See More

52-Week High 28.75
Fibonacci 61.8% 22.73
Fibonacci 50% 20.88
Fibonacci 38.2% 19.02
Last Price 18.35
52-Week Low 13.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar